Cytek Biosciences (CTKB) Free Cash Flow Growth (3y) (2023 - 2026)
Cytek Biosciences (CTKB) Free Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.36 Bn | 194.75 Bn | 7.27 Bn | 41.96% |
| 2 | Stryker | 129.99 Bn | 126.52 Bn | 4.50 Bn | 25.48% |
| 3 | Medtronic | 120.03 Bn | 110.81 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 74.30 Bn | 73.76 Bn | 3.85 Bn | 35.42% |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn | 250.09% |
| 6 | Dexcom | 34.71 Bn | 32.76 Bn | 830.00 Mn | 12.01% |
| 7 | GE HealthCare Technologies | 34.24 Bn | 32.13 Bn | 2.18 Bn | 35.65% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 20.87% |
| 9 | Steris | 23.30 Bn | 22.81 Bn | 684.20 Mn | 9.23% |
| 10 | Cytek Biosciences | 613.64 Mn | 539.80 Mn | 28.34 Mn | 41.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.14% |
| Mar 31, 2026 | -56.10% |
| Dec 31, 2025 | 103.90% |
| Sep 30, 2025 | 6.95% |
| Jun 30, 2025 | 26.55% |
| Mar 31, 2025 | 40.54% |
| Dec 31, 2024 | -22.68% |
| Sep 30, 2024 | 125.03% |
| Jun 30, 2024 | 50.02% |
| Mar 31, 2024 | 33.46% |
| Dec 31, 2023 | -0.95% |
| Sep 30, 2023 | -84.54% |